Display options
Cite
Attarian S, Vallat JM, Magy L, et al. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016;11(1):92doi: 10.1186/s13023-016-0463-6.
Attarian, S., Vallat, J. M., Magy, L., Funalot, B., Gonnaud, P. M., Lacour, A., Péréon, Y., Dubourg, O., Pouget, J., Micallef, J., Franques, J., Lefebvre, M. N., Ghorab, K., Al-Moussawi, M., Tiffreau, V., Preudhomme, M., Magot, A., Leclair-Visonneau, L., Stojkovic, T., Bossi, L., Lehert, P., Gilbert, W., Bertrand, V., Mandel, J., Milet, A., Hajj, R., Boudiaf, L., Scart-Grès, C., Nabirotchkin, S., Guedj, M., Chumakov, I., & Cohen, D. (2016). Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet journal of rare diseases, 11(1), 92. https://doi.org/10.1186/s13023-016-0463-6
Attarian, Shahram, et al. "Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A." Orphanet journal of rare diseases vol. 11,1 (2016): 92. doi: https://doi.org/10.1186/s13023-016-0463-6
Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2016 Jul 07;11(1):92. doi: 10.1186/s13023-016-0463-6. PMID: 27387831; PMCID: PMC4937550.
Copy Download .nbib Format: NLM
Share it on

Orphanet J Rare Dis. 2016 Jul 07;11(1):92. doi: 10.1186/s13023-016-0463-6.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Orphanet journal of rare diseases

Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Benoît Funalot, Pierre-Marie Gonnaud, Arnaud Lacour, Yann Péréon, Odile Dubourg, Jean Pouget, Joëlle Micallef, Jérôme Franques, Marie-Noëlle Lefebvre, Karima Ghorab, Mahmoud Al-Moussawi, Vincent Tiffreau, Marguerite Preudhomme, Armelle Magot, Laurène Leclair-Visonneau, Tanya Stojkovic, Laura Bossi, Philippe Lehert, Walter Gilbert, Viviane Bertrand, Jonas Mandel, Aude Milet, Rodolphe Hajj, Lamia Boudiaf, Catherine Scart-Grès, Serguei Nabirotchkin, Mickael Guedj, Ilya Chumakov, Daniel Cohen

Affiliations

  1. Centre de référence des maladies neuromusculaires et de la SLA, Pôle des neurosciences Cliniques, AP-HM et Aix Marseille Université, Marseille, France.
  2. CHU de Limoges - Hôpital Dupuytren, 2 Avenue Martin Luther King, 87042, Limoges, France.
  3. CHU Lyon Sud, 165 Chemin du Grand Revoyet, 69495, Lyon, France.
  4. CHRU de Lille - Hôpital Roger Salengro, rue Emile Laine, 59037, Lille, France.
  5. CHU de Nantes - Hôtel Dieu, 1 place Alexis Ricordeau, 44093, Nantes, France.
  6. CHU de Paris - Groupe Hospitalier Pitié-Salpétrière, 47-83 boulevard de l'Hôpital, 75013, Paris, France.
  7. CIC-Centre de Pharmacologie Clinique et D'Evaluations Therapeutiques, AP-HM et Aix Marseille Université, Marseille, France.
  8. Admissions, 75017, Paris, France.
  9. Faculty of Medicine, The University of Melbourne, Grattan St, Melbourne, VIC, 3010, Australia.
  10. Faculty of Economics, UCL Mons, Louvain, Belgium.
  11. Carl M. Loeb University Professor Emeritus, Harvard University, Cambridge, MA, 02138, USA.
  12. Pharnext, 11, rue des Peupliers, 92130 Issy-Les-Moulineaux, Paris, France.
  13. Pharnext, 11, rue des Peupliers, 92130 Issy-Les-Moulineaux, Paris, France. [email protected].

PMID: 27387831 PMCID: PMC4937550 DOI: 10.1186/s13023-016-0463-6

[No abstract available.]

References

  1. Orphanet J Rare Dis. 2014 Dec 18;9:199 - PubMed

Publication Types